OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2022-12-31-accounts

Charity Number: 1180844 CHARITABLE INCORPORATED ORGANISATION (CIO)

TISSUE VIABILITY SOCIETY (TVS) WORKING NAME: SOCIETY OF TISSUE VIABILITY

TRUSTEES' REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST DECEMBER 2022

NORTHOVER & CO ACCOUNTANTS LTD CHARTERED ACCOUNTANTS

132A BOURNEMOUTH ROAD CHANDLERS FORD, HAMPSHIRE SO53 3AL

TISSUE VIABILITY SOCIETY (TVS)

TABLE OF CONTENTS

Page 1 Legal & Administrative Information
Page 2 Independent Examiner's Report
Page 3 Income and Expenditure Account
Page 4 Comparative Income and Expenditure Account
Page 5 Balance Sheet
Pages 6 to 12 Notes to the Financial Statements
Appendix 1 Report of the Trustees

1.

TISSUE VIABILITY SOCIETY (TVS)

LEGAL AND ADMINISTRATIVE INFORMATION

Tissue Viability Society is an unincorporated entity and a registered charity governed by its memorandum and articles of association. The charity adopted a working name of Society of Tissue Viability, which was voted upon at the 2021 AGM and was formally adopted by the charity in February 2022. The legal name of the charity remains unchanged at this time.

CHARITY NUMBER 1180844 DATE OF REGISTRATION 26 November 2018

TRUSTEES

TRUSTEES
CHAIR Jeannie Donnelly
VICE-CHAIR Linda Primmer Resigned July 2022
Sarah Gardner From July 2022
TREASURER Fran Norman Until July 2022
David Hibbitt From July 2022
DEUPTY TREASURER Sarah Gardner Until July 2022
Kate Williams From July 2022
OTHER TRUSTEES Srinivasa Budithi Appointed July 2022
Ina Farrelly
Clare Greenwood
Natasha Levy
Liang Liu Resigned July 2022
Victoria Murray
Sharon Neill
Jane Nixon Resigned July 2022
Samantha Rooney Appointed July 2022
Sharon Scattergood Appointed July 2022
Joanna Swan
Gill Sykes
Connie Traynor
Samantha Wharton
Peter Worsley Appointed July 2022
PRINCIPAL ADDRESS Clinical Trials Research Unit
University of Leeds
Leeds
LS2 9JT
ACCOUNTANTS Northover & Co. Accountants Ltd
(Michael Northover TD FCA)
132A Bournemouth Road,
Chandlers Ford,
Hampshire
SO53 3AL
BANKERS Lloyds Bank PLC
120 Lewisham High Street
London
SE13 6JG

TISSUE VIABILITY SOCIETY (TVS)

2.

INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF TISSUE VIABILITY SOCIETY

I report on the accounts of the company for the year ended 31st December 2022 which are set out on pages 3 to 12.

RESPECTIVE RESPONSIBILITIES OF THE TRUSTEES AND EXAMINER

The trustees are responsible for the preparation of the accounts and they consider that an audit is not required for this year under section 144(2) of the Charities Act 2011 (the 2011 Act) and that an independent examination is permissible.

Having satisfied myself that the charity is not subject to an audit and is eligible for independent examination, it is my responsibility to:

examine the accounts under section 145 of the 2011 Act;

follow the procedures laid down in the general Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act; and

state whether particular matters have come to my attention.

BASIS OF INDEPENDENT EXAMINER’S REPORT

My examination was carried out in accordance with the general Directions given by the Charity Commission. An examination includes a review of the accounting records kept by the charity and a comparison of the accounts presented with those records. It also includes consideration of any unusual items or disclosures in the accounts, and seeking explanations from you as trustees concerning any such matters. The procedures undertaken do not provide all the evidence that would be required in an audit, and consequently no opinion is given as to whether the accounts present a "true and fair view" and the report is limited to those matters set out in the statement below.

INDEPENDENT EXAMINER’S STATEMENT

In connection with my examination, no matter has come to my attention:

to keep accounting records in accordance with section 386 of the Companies Act 2006; and

to prepare accounts which agree with the accounting records and comply with the accounting requirements of section 396 of the Companies act 2006 and with the methods and principles of the Statement of Recommended Practice: Accounting and Reporting by Charities

have not been met; or

Mike Northover

…....................................................................................................

07/09/23

Date…........................................................................................

M A Northover TD FCA on behalf of

NORTHOVER & CO ACCOUNTANTS LIMITED CHARTERED ACCOUNTANTS 132A BOURNEMOUTH ROAD CHANDLERS FORD, HAMPSHIRE

SO53 3AL

3.

TISSUE VIABILITY SOCIETY (TVS) STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31ST DECEMBER 2022

SUMMARY INCOME AND EXPENDITURE ACCOUNT

Notes
INCOMING RESOURCES
Incoming resources from generated funds
Project income
( 4 )
Subscriptions
Donations and legacies
( 6 )
Investment income
( 7 )
Other income
TOTAL INCOMING RESOURCES
RESOURCES EXPENDED
Project expenditure
( 4 )
Strategy/mission expenditure
( 8 )
Charitable activities
( 9 )
TOTAL EXPENDITURE
NET INCOMING RESOURCES
FOR THE YEAR BEFORE TRANSFERS
Transfers between funds
NET INCOME/(DEFICIT) FOR THE YEAR
Total funds brought forward
TOTAL FUNDS CARRIED FORWARD		 Notes Restricted Unrestricted
Funds
2022
2021
95,822
415,103
307,377
20,316
20,316
16,125
301
301
930
22
22
4
-
-
-
116,461
435,742
324,436
81,734
295,705
217,847
7,749
7,749
710
61,547
61,547
52,839
151,030
365,001
271,396
(34,569)
70,741
53,040
57,725
-
-
23,156
70,741
53,040
157,028
276,239
223,199
180,184
346,980
276,239
TOTAL FUNDS
Funds
319,281
-
-
-
-
319,281
213,971
-
-
213,971
105,310
(57,725)
47,585
119,212
166,797

The Income and Expenditure Account includes all gains and losses recognised in the year. All income and expenditure derives from continuing activities.

4.

TISSUE VIABILITY SOCIETY (TVS) STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31ST DECEMBER 2022

COMPARATIVE SUMMARY INCOME AND EXPENDITURE ACCOUNT

Notes
INCOMING RESOURCES
Incoming resources from generated funds
Project income
( 5 )
Subscriptions
Donations and legacies
( 6 )
Investment income
( 7 )
Other income
TOTAL INCOMING RESOURCES
RESOURCES EXPENDED
Project expenditure
( 5 )
Strategy/mission expenditure
( 8 )
Charitable activities
( 9 )
TOTAL EXPENDITURE
NET INCOMING RESOURCES
FOR THE YEAR BEFORE TRANSFERS
Transfers between funds
NET INCOME/(DEFICIT) FOR THE YEAR
Total funds brought forward
TOTAL FUNDS CARRIED FORWARD		 Restricted
Funds
202,545
-
-
-
-
202,545
161,366
-
-
161,366
41,179
4,000
45,179
74,033
119,212		 Unrestricted
Funds
104,832
16,125
930
4
-
121,891
56,481
710
52,839
110,030
11,861
(4,000)
7,861
149,166
157,027		 TOTAL
FUNDS
2021
307,377
16,125
930
4
-
324,436
217,847
710
52,839
271,396
53,040
-
53,040
223,199
276,239

5.

TISSUE VIABILITY SOCIETY (TVS) STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31ST DECEMBER 2022

CURRENT ASSETS
Debtors
Cash at bank and in hand
CREDITORS:
Amounts falling due within one year
NET CURRENT ASSETS
NET ASSETS
CAPITAL
Unrestricted funds
General fund
Restricted funds		 Notes

( 12 )
( 13 )
( 14 )
( 15 )		 2022

204,789
172,772
377,561
30,581
30,581
346,980
346,980
180,184
166,797
346,980		 2021
133,942
167,912
301,854
25,615
25,615
276,239
276,239
157,028
119,212
276,239

The financial statements were approved by the board on……..................................... 19 September 2023

and signed on its behalf by:

……………………………………….....................................

Jeannie Donnelly

Chair

TISSUE VIABILITY SOCIETY (TVS) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST DECEMBER 2022

6.

1 ACCOUNTING POLICIES

1.11 Basis of preparation of financial statements

The financial statements have been prepared in accordance with the Charities SORP (FRS 102) - Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Charities Act 2011.

Tissue Viability Society meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy.

1.12 Fund accounting

General funds are unrestricted funds which are available for use at the discretion of the Trustees in furtherance of the general objectives of the Charity and which have not been designated for other purposes.

Designated funds comprise unrestricted funds that have been set aside by the Trustees for particular purposes. The aim and use of each designated fund are set out in the notes to the financial statements.

Restricted funds are funds which are to be used in accordance with specific restrictions imposed by donors or which have been raised by the Charity for particular purposes. The costs of raising and administering such funds are charged against the specific fund.

1.13 Income

All income is recognised once the Charity has entitlement to the income, it is probable that the income will be received and the amount of income receivable can be measured reliably.

Income tax recoverable in relation to donations received under Gift Aid or deeds of covenant is recognised at the time of the donation.

1.14 Expenditure

Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably.

Governance costs are those incurred in connection with administration of the charity and compliance with constitutional and statutory requirements.

Costs of generating funds are costs incurred in attracting voluntary income, and those incurred in trading activities that raise funds.

1.15 Tangible fixed assets

The cost of tangible fixed assets, if any, is expended to the Income & Expenditure Account in the periods of acquisition.

Website design costs, if any, are written off in the year they are incurred.

1.16 Debtors

Trade and other debtors are recognised at the settlement amount after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.

1.17 Cash at bank and in hand

Cash at bank and in hand includes cash and short-term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.

1.18 Creditors

Creditors and provisions are recognised where the charity has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors and provisions are normally recognised at their settlement amount after allowing for any trade discounts due.

TISSUE VIABILITY SOCIETY (TVS) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST DECEMBER 2021

7.

1 ACCOUNTING POLICIES (cont.)

1.19 Financial instruments

The charity has elected to apply the provisions of Section 11 'Basic Financial Instruments' of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the charity's balance sheet when the charity becomes party to the contractual provisions of the instrument.

Basic financial assets, which include debtors and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities, including creditors, are initially recognised at transaction price and are subsequently carried at amortised cost using the effective interest method. Financial liabilities classified as payable within one year are not amortised.

1.20 Taxation

The charity is exempt from corporation tax on its charitable activities.

1.21 Going concern

At the time of approving the financial statements and after considering various possible levels of impact of Covid-19, the trustees have a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future. Thus the holding trustees continue to adopt the going concern basis of accounting in preparing the financial statements.

2 TRUSTEES' RESPONSIBILITIES IN RESPECT OF THE FINANCIAL STATEMENTS

The law applicable to charities in England and Wales requires the trustees to prepare financial statements for each financial period which give a true and fair view of the charity’s financial activities during the year and of its financial position at the end of the year. In preparing financial statements giving a true and fair view, the trustees should follow best practice and:

•select suitable accounting policies and then apply them consistently;

•make judgements and estimates that are reasonable and prudent;

•state whether applicable accounting standards and statements of recommended practice have been followed, subject to any departures disclosed and explained in the financial statements;

•prepare the financial statements on the going concern basis unless it is inappropriate to presume that the society will continue in operation.

The trustees are responsible for keeping accounting records which disclose with reasonable accuracy the financial position of the society and which enable them to ascertain the financial position of the society and which enable them to ensure that the financial statements comply with applicable law. They are also responsible for safeguarding the assets of the society and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

3 RESERVES POLICY

The charity regulations require the society to define its policy in respect of reserves.

The trustees consider that as it no longer has full time employees with a permanent base, that it hold sufficient reserves to insure that it can continue its activities satisfactorily for a period of least 12 months even if its income was significantly reduced. However the Trustees do consider the Charity’s ongoing viability on an annual basis. Any funds and ongoing income not required for immediate needs is put on deposit to maximise interest and drawn upon as required.

TISSUE VIABILITY SOCIETY (TVS) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST DECEMBER 2022

8.

4 TOTAL PROJECT INCOME & EXPENDITURE

PROJECT INCOME & EXPENDITURE - UNRESTRICTED

2022
Income
Expenditure
Surplus/
(Deficit)
Journals
31,632
23,352
8,280
Education Programme Facilitator
-
9,904
(9,904)
Corporate Sponsors - 40% donation element
40,880
-
40,880
Educational Endorsements
10,500
6,500
4,000
Study Days
12,810
21,945
(9,135)
Webinars
-
700
(700)
WReN
-
19,333
(19,333)
95,822
81,734
14,088
PROJECT INCOME & EXPENDITURE - RESTRICTED		 2021
Surplus/
(Deficit)
5,656
(1,383)
43,600
7,408
(2,382)
150
(4,698)
48,351
Educational Grants
TVS Conference
Legs Matter Project
Skin Care Champions
Stop the Pressure
TOTAL PROJECT INCOME & EXPENDITURE
Income
Expenditure
Surplus/
(Deficit)
415,103
295,705
119,398
5 TOTAL PROJECT INCOME & EXPENDITURE (COMPARATIVE)
PROJECT INCOME & EXPENDITURE - UNRESTRICTED (COMPARATIVE)		 TOTAL PROJECT INCOME & EXPENDITURE
Income
Expenditure
Surplus/
(Deficit)
415,103
295,705
119,398
TOTAL PROJECT INCOME & EXPENDITURE
Income
Expenditure
Surplus/
(Deficit)
415,103
295,705
119,398
**5 ** TOTAL PROJECT INCOME & EXPENDITURE (COMPARATIVE)
PROJECT INCOME & EXPENDITURE - UNRESTRICTED (COMPARATIVE)
Journals
Education Programme Facilitator
Corporate Sponsors - 40% donation element
Educational Endorsements
Study Days
Webinars
WReN		 Income
Expenditure
24,988
19,332
-
1,383
44,800
1,200
14,200
6,792
13,344
15,726
7,000
6,850
500
5,198
104,832
56,481		 2021
Surplus/
(Deficit)
5,656
(1,383)
43,600
7,408
(2,382)
150
(4,698)
48,351

TISSUE VIABILITY SOCIETY (TVS) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST DECEMBER 2022

9.

5 TOTAL PROJECT INCOME & EXPENDITURE (COMPARATIVE) (CONT.)

PROJECT INCOME & EXPENDITURE - RESTRICTED (COMPARATIVE)

Educational Grants
TVS Conference
Legs Matter Project
Skin Care Champions
Stop the Pressure		 Income
Expenditure
59,100
-
45,226
73,116
71,289
66,733
21,680
12,585
5,250
8,932
202,545
161,366		 Surplus/
(Deficit)
59,100
(27,890)
4,556
9,095
(3,682)
41,179
TOTAL PROJECT INCOME & EXPENDITURE (COMPARATIVE)
Income
Expenditure
307,377
217,847
6 DONATIONS AND LEGACIES
2022
Donations
301
7 INVESTMENT INCOME
2022
Interest receivable
22
8 STRATEGY/MISSION EXPENSES
2022
EPUAP
1,280
EWMA
1,794
Scholarships
4,467
Other conferences
208
7,749
9 CHARITABLE EXPENDITURE - UNRESTRICTED
2022
SUPPORT COSTS
Marketing, website and rebranding costs
38,220
Administration assistant
17,223
Council expenses - trustees fees
-
Printing, postage and stationery
28
Paypal charges
173
Bank charges
114
Just Giving charges
7
Insurance
1,270
Subscriptions
451
Training
-
Meeting expenses
632
Sundry expenses
229
58,347		 Surplus/
(Deficit)
89,530
2021
930
2021
4
2021
-
-
-
710
710
2021
28,908
17,124
-
53
150
86
22
1,163
346
-
266
427
48,545

TISSUE VIABILITY SOCIETY (TVS) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST DECEMBER 2022

10.

9 CHARITABLE EXPENDITURE - UNRESTRICTED (CONT.)
GOVERNANCE COSTS
Independent examination
Council expenses
TOTAL CHARITABLE EXPENDITURE		 2022
3,200
-
3,200
61,547		 2021
4,294
-
4,294
52,839

10 STAFF COSTS

The average number of staff employed during the year was 0 (2021: 0).

There were no employees whose annual remuneration was £60,000 or more.

11 TRUSTEES REMUNERATION AND EXPENSES

During the year, amounts were paid/reimbursed to the trustees of the charity as follows:

Speaker fees
Educational endorsement fees
Educational Programme Facilitator
Consultant fees
Travel expenses		 2022
2,040
-
8,464
1,794
2,781
15,079		 2021
950
908
-
-
366
2,224

Speaker fees were paid to 3 Trustees (2021: 1) for preparation and speaking at society Study Days.

Education endorsement fees were paid to 0 Trustees (2021: 2) for review work undertaken on educational materials as part of the Educational Endorsement offering.

Education Programme Facilitator fees were paid to 1 Trustee for consultancy work on the organisation of study days and other organisational work regarding the annual conferences and other charity services.

No remuneration was paid to any Trustees during the year.

12 DEBTORS

Trade debtors
Amounts due from Pink@Pink TVS Ltd
Prepayments and accrued income
13 CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
Trade creditors
Accruals and deferred income		 2022
31,632
172,022
1,135
204,789
2022
2,979
27,602
30,581		 2021
24,988
107,965
989
133,942
2021
1,441
24,174
25,615

11.

TISSUE VIABILITY SOCIETY (TVS) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST DECEMBER 2022

14 UNRESTRICTED FUNDS
General funds
15 RESTRICTED FUNDS
Educational Grants
TVS Conference
Legs Matter
Skin Care Champions
STOP the Pressure		 Funds
Funds
B/Fwd
Income
Expenditure
Transfers
C/Fwd
157,028
116,461
(151,030)
57,725
180,184
157,028
116,461
(151,030)
57,725
180,184
Funds
Funds
B/Fwd
Income
Expenditure
Transfers
C/Fwd
58,180
61,800
-
(119,980)
-
31,456
200,674
(171,517)
54,930
115,543
22,623
49,737
(20,681)
-
51,679
10,635
2,070
(14,773)
-
(2,068)
(3,682)
5,000
(7,000)
7,325
1,643
119,212
319,281
(213,971)
(57,725)
166,797

Educational Grants

The charity receives sponsorship through direct sponsorship or through our tiered corporate membership system to provide grants to healthcare professionals to enable them to attend the TVS conferences and exhibitions. The healthcare professionals will receive a grant to cover travel and accommodation costs for the event, as well as covering the cost of attending the events.

TVS Conference

The charity holds an annual conference covering a wide range of topics within the remit of the charity to enhance the knowledge and awareness of these topics for healthcare professionals across the country. The charity receives sponsorship and grants to enable this conference to be held.

Legs Matter

Legs Matter is a coalition of organisations working together to increase awareness, understanding and action on lower leg and foot conditions among the public and healthcare professionals through year-round activities and communications.

Skin Care Champions

Skin Care Champions provides people working in care homes and home care agencies a trusted programme of cost-effective and easily accessible education and support skin health and wound healing.

STOP the Pressure

Stop The Pressure aims to create a significant culture shift and eliminate avoidable pressure ulcers in acute, community and mental health provider settings through a variety of activities to support healthcare professional, including hosting free webinars with expert speakers leading informative sessions, putting together training sessions for organisations and developing graphics and posters which can be adapted locally.

16 ANALYSIS OF NET ASSETS BETWEEN FUNDS

As at 31 December 2022
Debtors
Bank and Cash
Creditors
As at 31 December 2021
Debtors
Bank and Cash
Creditors		 Unrestricted
Restricted
2022
42,967
161,822
204,789
167,797
4,975
172,772
(30,271)
(310)
(30,581)
180,493
166,487
346,980
Unrestricted
Restricted
2021
25,977
107,965
133,942
156,665
11,247
167,912
(25,615)
-
(25,615)
157,027
119,212
276,239

12.

TISSUE VIABILITY SOCIETY (TVS) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST DECEMBER 2022

17 RELATED PARTIES

Pink@Pink TVS Ltd is a company registered in England and Wales (Company Number: 08199801) which acts on behalf on Tissue Viability Society in the organisation and management of several of the charity's funds and events. The company is currently owned and managed by individuals whom are not trustees of the charity. The charity maintains oversight of the financial dealings of the company through regular management reporting by the company to the charity.

Listed below is an overall summary of the transactions which have been undertaken on behalf of the charity.

2022 2021
Income 383,058 266,392
Expenditure 319,001 246,361
Amounts due from Pink@Pink TVS Ltd - Disclosed within Debtors 172,022 107,965
Trustees' Annual Report for theperiod Trustees' Annual Report for theperiod Trustees' Annual Report for theperiod Trustees' Annual Report for theperiod Trustees' Annual Report for theperiod Trustees' Annual Report for theperiod Trustees' Annual Report for theperiod Trustees' Annual Report for theperiod
**From ** Period start date To Period end date
1st January 2022 31st December 2022
Section A Reference and administration details
Charity name
Registered charity number
Charity's principal address
Tissue Viability Society (TVS)
known as Society of Tissue Viability
1180844
c/o The Clinical Trials Research Unit, University of Leeds,
Leeds LS2 9JT

Names of the charity trustees who manage the charity. Trustees are elected by the council or members.

Trustee name Office (if any) Dates acted if not for whole year
1. Jeannie Donnelly Chair Since 2020, Chair since July2021
2. Sarah Gardner Vice Chair, Legs Matter
lead		 Since 2018, Vice Chair since July 2022
3. David Hibbitt Treasurer
Industryrepresentative		 Since 2018, Treasurer since July 2022
4. Kate Williams Vice Treasurer Since 2018, Vice Treasurer since July2022
5. Srinivasa Budithi Since 2022
6. Ina Farrelly Since 2019
7. Clare Greenwood Since 2021
8. Natasha Levy Since 2020
9. LiangLiu Since 2019, resigned July2022
10. Victoria Murray Industryrepresentative Since 2021
11. Sharon Neill Since 2020
12. Jane Nixon Since October 2020, resigned July2022
13. Frances Norman
(was Spratt)		 Since 2018
14. Linda Primmer Since 2018, resigned July2022
15. Samantha Rooney Since 2022
16. Sharon Scattergood Since 2022
17. Joanna Swan Since 2018
18. Gill Sykes Since 2018
19. Connie Traynor Since 2018
20. Samantha Wharton Since 2021
21. Peter Worsley Since 2022

Society of Tissue Viability Annual Report

1

July 2023

Section B Structure, governance and management

Description of the charity’s trusts

Type of governing Constitution document How the charity is A Council of Trustees constituted Trustee selection methods Appointed by Council or elected by membership depending upon number of available places and number of applicants.

Section C Objectives and activities

The objectives for which the Society is established are to promote learning and advance public education in the study of tissue viability and Summary of the objects of do all such things as may be conducive to improve standards in tissue the charity set out in its viability as a multi-professional activity. governing document

All Trustees are aware of the public benefit guidance issued by the Charity Commission and have had regard to this when making decisions to undertake activities.

The start of 2022 once again saw the Pandemic as a continuing threat to the Society’s plans, with the Board of Trustees assessing whether to postpone the Society’s annual conference in Glasgow, 18–19 May. A risk assessment considered factors such as strong enthusiasm for the conference, high educational grant applications, committed exhibitors and companies keen for a face to face conference to happen, versus the possibility of moving the conference to later in the year when pressure on the NHS might have eased, and assessing the financial risk if lock down was again reimposed, especially in respect of the different rules that Summary of the main activities undertaken for applied in Scotland. With everything taken into consideration, it was decided to move forward at risk with a face-to-face conference and this, the public benefit in as it turned out, proved to be the right decision. Our 2022 conference at relation to these objects Hampden Park, Glasgow was a resounding success and once again the highlight of the Society’s year. The conference was also an opportunity to showcase our new brand and ethos. Since 2020 Trustees had been working on a revised strategy and this work presented an opportunity to review the Tissue Viability Society’s (TVS) brand and website to make sure they were working as hard as they could to support the strategic ambitions of the Society. The world and tissue viability have changed since the inception of the TVS in 1980 and the Pandemic accelerated that change. The rebrand was an opportunity to take stock and reassess the role and relevance of the TVS and how it could be reflected in a new brand.

Society of Tissue Viability Annual Report

2

July 2023

Key findings from stakeholder interviews and a survey showed that the TVS had some great strengths – integrity, credibility, trust but there was lack of clarity about the mission and role of the Society; there was no strong sense of the value of membership or who it was for and there was a need to be more inter-disciplinary, not just a society for TVNs. Our working name was changed to the Society of Tissue Viability (a subtle yet powerful change) and our brand purpose was relaunched – ‘We use the power of collaborative thinking and action to solve skin and wound challenges’. We created a new visual identify with a new logo, a refreshed colour pallet, a range of illustrations to allow us to build recognition in a more unique way than using photography alone and, of course, a new website with enhanced functionality.

The impact of the new brand has been considerable across all areas of Society business. Our social media channels have shown significant engagement and growth and the increase in website page views has been remarkable. Prior to the website re-launch, we typically had 200 to 500 page views per day. This has now increased to an impressive 500 to 1,000+ page views per day and so demonstrating the undoubted success of the rebranding project. Coinciding with our change of name and new brand, our highly regarded journal, the Journal of Tissue Viability (JTV), also experienced a change in leadership and structure. In April 2022, Professor Dan Bader (now deceased) handed over the role of Editor in Chief to Professor Declan Patton of the School of Nursing and Midwifery, Royal College of Surgeons Ireland. Professor Bader remained on the editorial team as Emeritus Editor to assist in the handover and support the new editor. In addition, the Society’s links with the journal were strengthened with the inclusion of Trustees Clare Greenwood and Natasha Levy on the editorial board, and the appointment of existing board member Peter Worsley as a Trustee of the Society. Dan Bader was very proud to hand over the journal in such good shape, with the JTV securing its highest ever Impact Factor of 3.374 in 2022. Very sadly, in November 2022 Dan Bader unexpectedly died; this was not only a huge shock and loss to his family, but also to the Society and he is very much missed by all who knew him.

Below is a short summary providing further detail of the main activities the Society has undertaken in 2022 in support of its strategic objectives.

1. Membership Being a member of the Society of Tissue Viability means joining a community of some of the world’s best clinical experts and helping to shape and contribute to the science and research of skin health and wound healing. The Society was set up for all those who are passionate about solving skin and wound challenges and we welcome anyone who is interested in skin health and wound healing – whether professionally or personally. Over the course of 2022 our membership has grown strongly and by the close of the year stood at over 700 members. Many members are nurses, but our community also includes doctors, pharmacists, bioengineers, podiatrists, other allied health professionals, academics, researchers, clinical scientists and healthcare industry professionals and it is this diversity in our community that is one of our main strengths.

In 2022 we launched a new initiative for members, called the Active Associate, which is an opportunity for members to become more involved in the work of the Society. This new intitiavie followed on from our setting up in 2021 the Alumni group of former Trustees in order to retain their

Society of Tissue Viability Annual Report

3

July 2023

wealth of knowledge and organisational memory. The two groups were brought together under the banner of the Associate Forum and we officially launched this initiative at our conference in Glasgow. The Associate Forum had its first meeting in June 2022 and now has 26 Active Associate members. We hope that in time Active Associates will become embedded in the work streams of the Society and that the Forum may prove a stepping stone for members to ultimately take up the role of Trustee. We hope that the Forum will generate its own initiatives based on its members’ interests and areas of expertise which will go on to feed into our educational programmes and conference. 2. Conference It was a welcome return to a face-to-face meeting for our 2022 conference held at Hampden Park, Glasgow on 18–19 May. The conference was run in collaboration with the National Association of Tissue Viability Nurses Scotland (NATVNS) and we introduced industry sponsored breakfast symposia which were a great success. The packed two-day programme included lectures, discussion forums and workshops plus the Wounds Research Network’s 7th Scientific Meeting and a full day ‘Fundamentals in Skin Health and Wound Healing’ event. Attending conferences is one of the very best ways to access the latest knowledge and build invaluable professional connections, but we know the cost for individuals can be prohibitive. That is why the Society created educational grants, a simple, transparent and cost-effective way for us, with the support of our industry partners, to fund healthcare professionals to attend our annual conference, as well as other conferences. 419 Clinical delegates registered over the two days of the Glasgow conference, with 67 speakers, 47 exhibiting companies and 135 industry personnel registered. Coming out of the Pandemic, the event was a great success and gave us a platform to build on for the 2023 annual conference in Peterborough. A major focus of the 2022 conference was to continue with our commitment to a greener way of working – the programme booklet was very much reduced with all information accessed through our website, and any new conference materials were commissioned with a view to their reuse. Finally, by filming many sessions we are building up a valuable library of on-demand assets for our members’ future use which we believe will be invaluable to them.

Unfortunately, due to the uncertainty of Pandemic early in the year, Trustees took the tough decision not to attend EWMA 22 Paris as a Society. Later in the year, however, Trustees did attend EPUAP 22 in Prague and educational grants provided by the Society also supported two members to attend EPUAP. 3. Study sessions The Society offers regular, virtual education sessions for all, whether someone is just embarking on their career or has many years’ experience. These educational sessions are an invaluable way of increasing knowledge, and all sessions are free for delegates to attend.

In 2022 we changed the format of our Foundation study days. Previously these study days combined both pressure ulcers and wound care in one session and, while they proved extremely successful, in 2022 we moved to a programme that offered three Fundamental half-day sessions on:

Society of Tissue Viability Annual Report

July 2023

4

By revising the format, the Society was able to offer new and more indepth information to delegates. As part of this new format, in July 2022 we held a Fundamental study session on lower limb care specifically for our industry partners. The study session was designed to enhance their knowledge in order to support our members’ practice.

For all our study sessions, we continued to use the breakout room functionality in Zoom so our industry partners can showcase their products and services in a virtual exhibition environment. We consistently receive excellent feedback from both delegates and industry representatives for our Fundamental sessions.

Our Advanced study sessions, designed for those who are confident in wound assessment and dressing selection, included full-day events on:

Service specific study session topics included

During 2022 we educated a total of 1,369 healthcare professionals, and from January to June 2023 we have so far educated a total of 930.

For the second half of 2023, we are making some changes to our study sessions in order to enhance the experience, both for attendees and our industry supporters. In future we will be using Zoom Webinar and utilising the breakout room facility, offering industry time within the programme to take over the ‘main stage’ in order that they can present to the whole audience about their products and services.

Webinars The Society continues to run webinars both independently and in partnership with commercial organisations. Both options have resulted in extremely lively sessions with a valuable learning experience for all delegates and lots of questions. Webinars held over 2022 and to date in 2023 include:

All webinars were viewable live on Zoom and streamed to the Facebook Live platform. Following the event, they were made available to watch ondemand on the Society’s website and YouTube channel. Over 2,000 people viewed these events on the various channels, and they are continuing to get views.

Society of Tissue Viability Annual Report

July 2023

5

Skin Care Champions

The Society created the Skin Care Champions programme to provide people working in care homes and home care agencies with trusted, cost-effective and easily accessible education that supports skin health and wound healing. Our ambition is to create and empower a Skin Care Champion for every care home or agency that joins the programme – someone who can help to make sure that excellent care is provided to their clients and residents and be seen a source of information and knowledge for their peers.

Following the launch of our Skin Care Champion programme in 2021, we ran a second cohort in 2022 with 34 champions enrolled. While the monthly meetings achieved relatively low attendance figures, our website’s statistics clearly showed that the meeting recordings and module information were being viewed and downloaded regularly. The programme was once again very well evaluated with participants particularly appreciating the supportive community of like-minded people and the opportunity to share experiences with the network.

Our Skin Care Champions programme is delivered by Heidi Sandoz, a highly respected leading educator in wound care. Under Heidi’s guidance the Skin Care Champions programme has continued to gain momentum by word of mouth and through social channels. This, combined with a noticeable increase in engagement shown by our second cohort, convinced Trustees to support a third cohort of champions. In addition, the financial model for the programme was rethought and included applying to 3M for a grant, which we were awarded in April 2023.

A third cohort of Skin Care Champions started in May 2023 and it really feels like the Society’s vision to ‘ignite the potential for great skin care in the social care sector’ is starting to come together as the 2023 programme has 81 champions registered.

Education Endorsement

A core part of the Society’s mission is to make sure that the best new thinking and practice in skin health and wound healing reaches the people it needs to. Our offering of Education Endorsement is a part of fulfilling this. We are proud to work with our industry partners and other not-for-profit organisations to help bring more high-quality, independent education to people with an interest in skin health and wound healing. During 2022 we endorsed 7 educational modules, for 2 organisations and so far during 2023, have endorsed 3 modules for 1 organisation, with many renewals and new materials to be endorsed in the pipeline for the second half of 2023.

4. Project work / consultations

The Society is regularly approached by external organisations nationally to offer opinion or consultation on work they may be doing. Largely this kind of work is undertaken without consulting the membership, but we are always mindful that we represent our membership when we respond. Project work and consultations this year have included:

v Legs Matter Campaign:

Legs Matter continues to actively raise awareness of lower limb and foot health, gaining interest from both patients and the public as well as healthcare professionals.

v The campaign is run by a coalition of like-minded organisations under the governance of the Society. In 2022 the coalition

Society of Tissue Viability Annual Report

6

July 2023

Society of Tissue Viability Annual Report

July 2023

7

The 7[th] annual Scientific Meeting of the Wounds Research Network (WReN) was held as part of our 2022 Conference in Glasgow. The theme of the meeting was around implementation, showcasing how research funded by National Institute for Health and Care Research (NIHR) is changing practice.

v NHS England:

The Society continues to work with NHS England Improvement to lead a programme of change for the wound care population of England.

Society of Tissue Viability Annual Report

8

July 2023

clinical practice. Following the NWCSP’s approach, the Society developed a survey for newly qualified healthcare professionals in order to understand how the level of education students receive correlates with their level of preparedness and confidence at the start of their practice as newly qualified healthcare professionals. v Also during 2022, the Society continued to engage with NHS Supply Chain, using the proper channels to raise clinicians concerns around sourcing specialist products. Keen to ensure that the views of our members and other healthcare professionals were represented in a clear and unbiased way, we developed a survey around the procurement of wound care products and therapies and the evidence for their use. v Both surveys were launched in November 2022 and continue to be open for submissions at the time of writing. v Nurses Specialized in Wound, Ostomy and Continence Canada (NSWOCC) : In 2022 the Society continued collaborative working with NSWOCC around producing a joint consensus document on best practice in relation to sharp debridement. This collaborative document is due for publication in 2023. v International Skin Tear Advisory Panel (ISTAP): In 2021 the Society signed a memorandum of understanding with the International Skin Tear Advisory Panel to form a partnership to raise awareness about the prevention and management of skin tears and skin breakdown. On 28 April 2022 the Society supported ISTAP’s inaugural global ‘A World Without Skin Tears’ Day via our social media channels and website.

5. Journal of Tissue Viability The Society’s journal, the Journal of Tissue Viability (JTV), is a high quality, peer reviewed journal that has an international readership. It is free to members and available to purchase on subscription by nonmembers.

The JTV has seen a healthy increase in submissions over the past 4 years, with 293 articles submitted to the journal in 2022, showing an increase of 18% compared to 2021. Looking at 2023 year to date, the journal has seen a significant increase of 36% in submissions compared to January–June 2022. In terms of geographical performance, as has been the trend since 2019, submissions from Asia dominate and the gap between Asia and Europe widens year by year.

As a journal of interest to readers worldwide, the JTV’s Science Direct portal broke the barrier of 200,000 users in 2022, with 45% of users originating in the United States. In addition, the usage figures in Clinical Key increased by 30% in 2022, peaking at 11,896. The journal was given an Impact Factor (IF) for 2021 (reported in 2022) of 3.374 (2020 IF 2.932) due to a huge 41% increase in citations to the JTV. The JTV went up significantly in ranking within the Nursing category – ranked 13 (first quartile); Dermatology category rank 24 (second quartile). For 2022 (reported in 2023) the journal has been given an IF of 2.5, ranking it as 34/123 (second quartile) in Nursing category and 33/70 (second quartile) in Dermatology category. An increase was also seen in CiteScore from 3.1 (2021) to 3.5 (2022), with the journal ranking as 43/133 in Dermatology category and as 76/193 in Pathology and Forensic Medicine category.

Society of Tissue Viability Annual Report

9

July 2023

7. Wider public engagement and public benefit

The Society contracts PINK Marketing to support its wider administrative needs, including conference organisation, involvement in strategy and projects, and managing our digital presence. In the 2022–2023 sponsorship year (1 June 2022–31 May 2023), PINK Marketing secured support from 18 industry sponsors to provide financial support as corporate partners for the Society.

PINK manage the Society’s social media accounts. By year end, followers of the Society’s Twitter account had increased to 6,832 (up by 14.1%), Facebook to 5,4341 followers (up by 13.9%), LinkedIn to 1,955 (up by 25.9%), and Instagram increased to 295 followers (up by 57.8%). In addition, at the end of 2022 there were 5,087 people subscribed to receive the Society’s informative e-newsletter.

Society of Tissue Viability Annual Report

10

July 2023

Section D Achievements and performance

Summary of the main achievements of the charity during the year

Highlights of the Society’s achievements in 2022:

Society of Tissue Viability Annual Report

11

July 2023

Section D Achievements and performance qualified healthcare professionals; and a second around the procurement of wound care products and therapies and the evidence for their use. Both these surveys were confined to NHS England practitioners. • Journal of Tissue Viability : The JTV also saw a big rise in its Impact Factor to 3.374 and its Science Direct portal broke the barrier of 200,000 users. In 2022 Professor Declan Patton was appointed the new Editor in Chief.

Credit and thanks must go to the Society’s dedicated Trustees and all those associated with our Council including PINK Marketing (Sue Simmonds, Kerry Wiles and Dawn Rush) and administrator Charlotte Hurdman, all of whom work consistently hard and passionately for the charity. Not forgetting our enthusiastic members, partners in industry and Journal of Tissue Viability without whom the Society would not be what it is today. The Council of Trustees and Society of Tissue Viability is comprised of people united in their passion for wound care and skin health and their drive to help solve the challenges of wound care as part of a much wider collaborative approach.

Section E Financial review

The Trustees are committed to maintaining financial reserves equivalent Brief statement of the to one year’s running costs. charity’s policy on reserves Details of any funds The Society is not currently in deficit materially in deficit

Section F Other optional information

Section G Declaration

The trustees declare that they have approved the trustees’ report above.

Signed on behalf of the charity’s trustees

Section G Declaration Section G Declaration Section G Declaration
The trustees declare that they have approved the trustees’ report above.
Signed on behalf of the charity’s trustees
Signature(s)
Full name(s) Elizabeth Jean Donnelly
Position (e.g. Secretary,
Chair, etc.)		 Chair of the Council of Trustees
Date 06/09/2023

Society of Tissue Viability Annual Report

12

July 2023